Related Experiment Video
Updated: Jun 15, 2026

A Drosophila Model to Study Wound-induced Polyploidization
Published on: June 9, 2020
A decrease in cyclin B1 levels leads to polyploidization in DNA damage-induced senescence
Ikue Kikuchi1, Yuji Nakayama, Takao Morinaga
1Department of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 2608675, Japan.
Abstract:
Adriamycin, an anthracycline antibiotic, has been used for the treatment of various types of tumours. Adriamycin induces at least two distinct types of growth repression, such as senescence and apoptosis, in a concentration-dependent manner. Cellular senescence is a condition in which cells are unable to proliferate further, and senescent cells frequently show polyploidy. Although abrogation of cell division is thought to correlate with polyploidization, the mechanisms underlying induction of polyploidization in senescent cells are largely unclear. We wished, therefore, to explore the role of cyclin B1 level in polyploidization of Adriamycin-induced senescent cells. A subcytotoxic concentration of Adriamycin induced polyploid cells having the features of senescence, such as flattened and enlarged cell shape and activated beta-galactosidase activity. In DNA damage-induced senescent cells, the levels of cyclin B1 were transiently increased and subsequently decreased. The decrease in cyclin B1 levels occurred in G2 cells during polyploidization upon treatment with a subcytotoxic concentration of Adriamycin. In contrast, neither polyploidy nor a decrease in cyclin B1 levels was induced by treatment with a cytotoxic concentration of Adriamycin. These results suggest that a decrease in cyclin B1 levels is induced by DNA damage, resulting in polyploidization in DNA damage-induced senescence.
Insights
Adriamycin treatment can cause cancer cells to enter senescence and become polyploid. A decrease in cyclin B1 levels is linked to this polyploidization in DNA damage-induced senescence.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Adriamycin (doxorubicin) is an anthracycline antibiotic used in cancer chemotherapy.
- Adriamycin induces cellular senescence and apoptosis in a concentration-dependent manner.
- Cellular senescence is characterized by irreversible growth arrest and often polyploidy, but the underlying mechanisms are not fully understood.
Purpose of the Study:
- To investigate the role of cyclin B1 levels in Adriamycin-induced polyploidization during cellular senescence.
- To elucidate the mechanisms connecting DNA damage, cyclin B1 regulation, and polyploidy in senescent cells.
Main Methods:
- Treatment of cancer cells with varying concentrations of Adriamycin.
- Assessment of cellular senescence markers (e.g., cell morphology, beta-galactosidase activity).
- Analysis of cyclin B1 protein levels in different cell cycle phases (G1, S, G2/M).
Main Results:
- Subcytotoxic Adriamycin concentrations induced senescent cells with polyploidy and increased beta-galactosidase activity.
- In DNA damage-induced senescent cells, cyclin B1 levels initially increased then decreased.
- A decrease in cyclin B1 levels was observed in G2 phase cells undergoing polyploidization with subcytotoxic Adriamycin.
- Cytotoxic Adriamycin concentrations did not induce polyploidy or a decrease in cyclin B1 levels.
Conclusions:
- A decrease in cyclin B1 levels is a key event in Adriamycin-induced polyploidization during DNA damage-induced senescence.
- This suggests a mechanism where DNA damage triggers a reduction in cyclin B1, leading to polyploidy in senescent cells.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Positive Regulator Molecules

